1. Home
  2. SCD vs NBTX Comparison

SCD vs NBTX Comparison

Compare SCD & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LMP Capital and Income Fund Inc.

SCD

LMP Capital and Income Fund Inc.

HOLD

Current Price

$14.82

Market Cap

357.8M

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$33.33

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCD
NBTX
Founded
2003
2003
Country
United States
France
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
357.8M
2.0B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SCD
NBTX
Price
$14.82
$33.33
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $36.00
AVG Volume (30 Days)
65.9K
★ 123.5K
Earning Date
01-01-0001
03-31-2026
Dividend Yield
★ 9.63%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$58.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.79
$14.78
52 Week High
$16.18
$57.14

Technical Indicators

Market Signals
Indicator
SCD
NBTX
Relative Strength Index (RSI) 25.15 38.87
Support Level $14.56 $32.40
Resistance Level $15.59 $34.66
Average True Range (ATR) 0.22 1.80
MACD -0.05 -0.33
Stochastic Oscillator 7.76 22.69

Price Performance

Historical Comparison
SCD
NBTX

About SCD LMP Capital and Income Fund Inc.

Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: